{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:39:00Z","timestamp":1762101540200,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jcms.2014.03.018","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T01:32:51Z","timestamp":1396402371000},"page":"1322-1328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Influence of epidermal growth factor receptor expression on the cetuximab and panitumumab response rates of head and neck carcinoma cells"],"prefix":"10.1016","volume":"42","author":[{"given":"Stefan","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Seher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman C.","family":"Brands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Linz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grit","family":"Lessner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander C.","family":"K\u00fcbler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urs D.A.","family":"M\u00fcller-Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcms.2014.03.018_bib1","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1200\/JCO.2012.45.4272","article-title":"Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trial","volume":"31","author":"Argiris","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcms.2014.03.018_bib2","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.bios.2010.02.029","article-title":"Real-time electrical impedance detection of cellular activities of oral cancer cells","volume":"25","author":"Arias","year":"2010","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.jcms.2014.03.018_bib3","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.ejca.2013.03.005","article-title":"A\u00a0patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer","volume":"49","author":"Bahassi el","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jcms.2014.03.018_bib4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jcms.2013.01.040","article-title":"Amplification of the PPFIA1 gene region on 11q13 in oral squamous cell carcinomas (OSCC)","volume":"41","author":"Blessmann","year":"2013","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2014.03.018_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/CCO.0b013e3283510773","article-title":"Treatment options for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, who progress after platinum-based chemotherapy","volume":"24","author":"de Andrade","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jcms.2014.03.018_bib6","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1200\/JCO.2009.27.6360","article-title":"Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape","volume":"28","author":"Ferris","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcms.2014.03.018_bib7","first-page":"3579","article-title":"Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer","volume":"53","author":"Grandis","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcms.2014.03.018_bib8","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/ijc.24533","article-title":"Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States","volume":"125","author":"Gupta","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcms.2014.03.018_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00784-013-0936-0","article-title":"Correlation of MAGE-A tumor antigens and the efficacy of various chemotherapeutic agents in head and neck carcinoma cells","volume":"18","author":"Hartmann","year":"2014","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.jcms.2014.03.018_bib10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jcms.2012.12.006","article-title":"Efficacy of cetuximab and panitumumab in oral squamous cell carcinoma cell lines: prognostic value of MAGE-A subgroups for treatment success","volume":"41","author":"Hartmann","year":"2013","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2014.03.018_bib11","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/01.cad.0000217425.44584.9f","article-title":"Lack of usefulness of epidermal growth factor receptor expression determination for cetuximab therapy in patients with colorectal cancer","volume":"17","author":"Hebbar","year":"2006","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jcms.2014.03.018_bib12","first-page":"5167","article-title":"Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines","volume":"49","author":"Heo","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcms.2014.03.018_bib13","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","article-title":"Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world","volume":"24","author":"Kamangar","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcms.2014.03.018_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hed.20859","article-title":"Emerging perspectives in epidermal growth factor receptor targeting in head and neck cancer","volume":"30","author":"Kim","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.jcms.2014.03.018_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcms.2012.05.005","article-title":"The role of clinical versus histopathological staging in patients with advanced oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy followed by radical surgery","volume":"41","author":"Kreppel","year":"2013","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2014.03.018_bib16","first-page":"3905","article-title":"Circulating tumor cell (CTC) count and epithelial growth factor receptor expression on CTCs as biomarkers for cetuximab efficacy in advanced colorectal cancer","volume":"33","author":"Kuboki","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jcms.2014.03.018_bib17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12026-011-8231-0","article-title":"Natural killer (NK): dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity","volume":"50","author":"Lee","year":"2011","journal-title":"Immunol Res"},{"key":"10.1016\/j.jcms.2014.03.018_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000355194","article-title":"Cisplatin versus cetuximab given concurrently with definitive radiation therapy for locally advanced head and neck squamous cell carcinoma","volume":"85","author":"Ley","year":"2013","journal-title":"Oncology"},{"key":"10.1016\/j.jcms.2014.03.018_bib19","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/annonc\/mdq588","article-title":"Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and\/or metastatic squamous cell carcinoma of the head and neck: EXTREME study","volume":"22","author":"Licitra","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcms.2014.03.018_bib20","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ejca.2012.11.018","article-title":"Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studies","volume":"49","author":"Licitra","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jcms.2014.03.018_bib21","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1200\/JCO.2012.46.3299","article-title":"Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial","volume":"31","author":"Martins","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcms.2014.03.018_bib22","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ijc.2910520605","article-title":"EGF receptor expression in primary laryngeal cancer: correlation with clinico-pathological features and prognostic significance","volume":"52","author":"Maurizi","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcms.2014.03.018_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nm.2609","article-title":"Identification of a mutation in the extracellular domain of the epidermal growth factor receptor conferring cetuximab resistance in colorectal cancer","volume":"18","author":"Montagut","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jcms.2014.03.018_bib24","first-page":"111","article-title":"Prognostic significance of epidermal growth factor receptor in surgically treated squamous cell lung cancer patients","volume":"42","author":"Niemiec","year":"2004","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1016\/j.jcms.2014.03.018_bib25","article-title":"Concurrent chemoradiotherapy with cisplatin versus cetuximab for squamous cell carcinoma of the head and neck","author":"Riaz","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jcms.2014.03.018_bib26","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1586\/era.09.113","article-title":"Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial","volume":"9","author":"Rivera","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jcms.2014.03.018_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0964-1955(92)90043-Z","article-title":"Amplification and overexpression of epidermal growth factor receptor gene in human oropharyngeal cancer","volume":"28B","author":"Saranath","year":"1992","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"10.1016\/j.jcms.2014.03.018_bib28","doi-asserted-by":"crossref","first-page":"e66302","DOI":"10.1371\/journal.pone.0066302","article-title":"Expression of epidermal growth factor receptor detected by cetuximab indicates its efficacy to Inhibit and Proliferation of colorectal Cancer cells","volume":"8","author":"Shigeta","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.jcms.2014.03.018_bib29","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4149\/neo_2012_065","article-title":"Epidermal growth factor receptor (EGFR) expression and mutations in the EGFR signaling pathway in correlation with anti-EGFR therapy in head and neck squamous cell carcinomas","volume":"59","author":"Smilek","year":"2012","journal-title":"Neoplasma"},{"key":"10.1016\/j.jcms.2014.03.018_bib30","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1158\/1078-0432.CCR-12-2426","article-title":"Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients","volume":"19","author":"Srivastava","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcms.2014.03.018_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcms.2011.02.001","article-title":"The role of elective supraomohyoidal neck dissection in the treatment of early, node-negative oral squamous cell carcinoma (OSCC): a retrospective analysis of 122 cases","volume":"40","author":"Thiele","year":"2012","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2014.03.018_bib32","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1002\/cncr.23442","article-title":"Overview of the efficacy of cetuximab in recurrent and\/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies","volume":"112","author":"Vermorken","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jcms.2014.03.018_bib33","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcms.2014.03.018_bib34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1470-2045(13)70181-5","article-title":"Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial","volume":"14","author":"Vermorken","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcms.2014.03.018_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10637-009-9341-6","article-title":"A\u00a0phase II, multicenter study of cetuximab monotherapy in patients with refractory, metastatic colorectal carcinoma with absent epidermal growth factor receptor immunostaining","volume":"29","author":"Wierzbicki","year":"2011","journal-title":"Invest New Drugs"}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518214000985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518214000985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:30:06Z","timestamp":1760884206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518214000985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1010518214000985"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2014.03.018","relation":{},"ISSN":["1010-5182"],"issn-type":[{"type":"print","value":"1010-5182"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of epidermal growth factor receptor expression on the cetuximab and panitumumab response rates of head and neck carcinoma cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2014.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}